MedTrace Logo

Feasibility Study of the NEW NORMA-SENSE

NCT00324246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2008-06-20

No results posted yet for this study

Summary

* In-vitro study
* Collect data regarding the color appearance on the new developed indicator strips (NEW NORMA-SENSE), in contact with vaginal secretion with elevated pH
* Measure the buffering capacity of vaginal secretion from non-symptomatic and symptomatic subjects
* Detect these indicator strips' performance, in contact with urine

Conditions

  • Vaginal Infection

Sponsors & Collaborators

  • Lin Medical Center, Haifa

    collaborator OTHER

  • Common Sense

    collaborator OTHER

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Adam Geva, MD · Women Health Care Center - Lin Medical Center, Haifa, Israel

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Completion
2007-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00324246 on ClinicalTrials.gov